CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-01 | Bowden Christopher Chief Medical Officer | Exercise or conversion · Stock option (right to buy) | −5,000 | 132,000 | ||
| 2015-05-29 | NELSEN ROBERT Director | Other disposition | −300,000 | 2,402,516 | ||
| 2015-05-29 | NELSEN ROBERT Director | Other acquisition | +1,733 | 8,422 | ||
| 2015-05-27 | Schenkein David P Chief Executive Officer | Sale | −8,929 | $120.05 | $1.1M | 85,582 |
| 2015-05-27 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion | +2,171 | $23.10 | $50K | 2,171 |
| 2015-05-27 | Goddard Glenn Senior Vice President, Finance | Sale | −2,171 | $120.05 | $261K | 0 |
| 2015-05-27 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Stock option (right to buy) | −2,171 | 109,098 | ||
| 2015-05-20 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $116.60 | $283K | 167,262 |
| 2015-05-20 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $116.60 | $283K | 167,262 |
| 2015-05-19 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $116.69 | $283K | 169,688 |
| 2015-05-19 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $116.66 | $283K | 169,688 |
| 2015-05-15 | Higgons John Duncan Chief Operating Officer | Sale | −7,417 | $112.89 | $837K | 98,835 |
| 2015-05-12 | Schenkein David P Chief Executive Officer | Sale | −2,093 | $110.03 | $230K | 94,701 |
| 2015-05-11 | Schenkein David P Chief Executive Officer | Sale | −3,107 | $110.01 | $342K | 96,794 |
| 2015-05-11 | NELSEN ROBERT Director | Other disposition | −386,074 | 2,702,516 | ||
| 2015-05-11 | NELSEN ROBERT Director | Other acquisition | +2,229 | 6,689 | ||
| 2015-05-08 | Schenkein David P Chief Executive Officer | Sale | −2,600 | $101.32 | $263K | 238,772 |
| 2015-05-08 | Schenkein David P Chief Executive Officer | Sale | −1,300 | $101.32 | $132K | 99,901 |
| 2015-05-07 | Biller Scott Chief Scientific Officer | Sale | −5,500 | $96.32 | $530K | 34,070 |
| 2015-05-07 | Schenkein David P Chief Executive Officer | Exercise or conversion | +10,000 | $0.30 | $3K | 241,372 |
Page 91 of 93 · 1,853 trades